Nuveen Asset Management, LLC Seres Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.33 - $5.07 $3,411 - $7,422	-1,464 Reduced 0.52%	279,471 $665,000
Q2 2023 Aug 14, 2023	SELL	$4.67 - $6.55 $414,509 - $581,378	-88,760 Reduced 24.01%	280,935 $1.35 Million
Q1 2023 May 15, 2023	BUY	$4.95 - $6.09 $323,274 - $397,725	65,308 Added 21.46%	369,695 $2.1 Million
Q4 2022 Feb 14, 2023	SELL	$5.09 - $9.05 $816,049 - $1.45 Million	-160,324 Reduced 34.5%	304,387 $1.71 Million
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $909,471 - $1.87 Million	259,849 Added 126.84%	464,711 $2.98 Million
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $132,375 - $373,593	-49,028 Reduced 19.31%	204,862 $702,000
Q1 2022 May 16, 2022	BUY	$6.3 - $8.84 $82,208 - $115,353	13,049 Added 5.42%	253,890 $1.85 Million
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $1.6 Million - $3.04 Million	-265,675 Reduced 52.45%	240,841 $1.92 Million
Q3 2021 Nov 12, 2021	BUY	$5.46 - $22.6 $1.22 Million - $5.04 Million	223,160 Added 78.76%	506,516 $3.61 Million
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $1.14 Million - $1.51 Million	61,859 Added 27.93%	283,356 $1.31 Million
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $32,370 - $53,010	-1,833 Reduced 0.82%	221,497 $1.03 Million
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $92,046 - $149,373	3,959 Added 1.8%	223,330 $1.04 Million
Q3 2020 Nov 16, 2020	SELL	$3.74 - $28.74 $144,648 - $1.11 Million	-38,676 Reduced 14.99%	219,371 $1.02 Million
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $77,130 - $157,306	25,372 Added 10.9%	258,047 $1.23 Million
Q1 2020 May 14, 2020	SELL	$2.64 - $3.82 $43,187 - $62,491	-16,359 Reduced 6.57%	232,675 $830,000
Q4 2019 Feb 14, 2020	SELL	$2.99 - $4.42 $323,879 - $478,778	-108,321 Reduced 30.31%	249,034 $859,000
Q3 2019 Nov 14, 2019	BUY	$2.29 - $4.16 $628,160 - $1.14 Million	274,306 Added 330.29%	357,355 $1.43 Million
Q2 2019 Aug 15, 2019	BUY	$2.28 - $7.35 $189,351 - $610,410	83,049 New	83,049 $267,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

46.3M

Call Options Held

119K

Put Options Held

466K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$21.3 Million
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

6.29M
Shares

$5.78 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.41M
Shares

$2.21 Million
0.21% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.78M
Shares

$1.64 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.76M
Shares

$1.62 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account